How Investment Bankers are Different than Brokers
How Investment Bankers are Different than Brokers
Why Dental Business Owners Choose Bankers Over Brokers
When it comes time to sell, many dental practice... Read more.
Breaking Down the FOCUS Sell-Side Process
Breaking Down the FOCUS Sell-Side Process
FOCUS Investment Banking is a leading sell-side advisor serving middle market companies. Our clients are usually... Read more.
2025 Dental Transactions Update
2025 Dental Transactions Update
As of June 2025, our research shows approximately 130 private equity backed DSOs operating across the dental services landscape... Read more.
Sitwell Dental Case Study
Sitwell Dental Case Study
Sitwell Dental, a trusted name in family dentistry with four locations across Saratoga County, is recognized for its comprehensive,... Read more.
FOCUS Investment Banking Represents Sitwell Dental in its Sale to SALT Dental Partners
FOCUS Investment Banking Represents Sitwell Dental in its Sale to SALT Dental Partners
Washington, DC, (June 23, 2024) – FOCUS Investment Banking (“FOCUS”),... Read more.
Infusion Therapy Services Market Update: Q1 2025
Infusion Therapy Services Market Update
Investments in the infusion therapy services market have increased rapidly since 2016, with no signs of slowing.... Read more.
More Varied Deal Structures Among Healthcare Providers are Another Reason Sellers Need Competitive Auctions
More Varied Deal Structures Among Healthcare Providers are Another Reason Sellers Need Competitive Auctions
Private equity investments in healthcare provider... Read more.
The Hottest Healthcare Services Verticals for Private Equity in 2025
Behavioral Health, Infusion, and Staffing firms top the list in BRG’s survey
Many lower middle market private equity groups have revisited their investment... Read more.
Momentum Builds for Ophthalmology Recapitalizations
McKesson’s acquisition of PRISM Vision Group is an important milestone for private equity’s investments in ophthalmology practices.
McKesson Corporation’s... Read more.
2025 Could Be the Year of the Retina Practice Deal
2025 Could Be the Year of the Retina Practice Deal
Momentum is building around retina practice transactions following Cencora’s November announcement that... Read more.
FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy
FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy
Washington, DC, (September 27, 2024) – FOCUS Investment... Read more.
FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
Washington, DC, (September 27, 2024) – FOCUS Investment... Read more.
ENT & Allergy – 2024 Update: Conservative Pace Continues
ENT & Allergy – 2024 Update: Conservative Pace Continues
Summary
Private equity-backed Physician Practice Management (“PPM”) companies in the... Read more.
Ophthalmology – 2024 Update: Entering a Mature Stage
Ophthalmology – 2024 Update: Entering a Mature Stage
Summary
Private equity’s investments in ophthalmology are entering a new, more mature lifecycle... Read more.
Ophthalmology 2024 Update
Ophthalmology 2024 Update
Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We expect continued transaction... Read more.